Docket #: S11-232
Treatment of Ocular Diseases Using Device Which Modulates Pathological Neural Pathways
Stanford researchers have developed a device and method aimed at intranasal neurostimulation for treating ocular diseases. As a non-surgical and non-implantable device, this system can be used at home by patients as needed to treat a diseases such as dry eye, eye twitch, allergies, occular migrane etc. Many of these diseases are currently ineffectively managed using pharmaceuticals and this system is able to provide improved patient outcomes with fewer overall side effects.
Stage of development
FDA cleared
Applications
- Treatment of Various Ocular Conditions:
- Dry eye, Eye twitch, Glaucoma
- Allergy, Ocular Migraine, etc
- Implantable Medical Devices
Advantages
- Increased efficacy expected
Patents
- Published Application: WO2012068247
- Published Application: 20120130398
- Published Application: 20150088156
- Published Application: 20150335900
- Published Application: 20180064940
- Published Application: 20180064941
- Published Application: 20180154161
- Published Application: 20190290922
- Published Application: 20210008379
- Published Application: 20230405339
- Issued: 8,918,181 (USA)
- Issued: 9,821,159 (USA)
- Issued: 10,835,748 (USA)
- Issued: 10,143,846 (USA)
- Issued: 10,722,718 (USA)
- Issued: 11,771,908 (USA)
Similar Technologies
-
Optical Tissue Interface S07-040Optical Tissue Interface
-
Redshifted Optogenetic Excitation: A Novel Tool for Fast Neural Control Derived from Volvox carteri S08-105Redshifted Optogenetic Excitation: A Novel Tool for Fast Neural Control Derived from Volvox carteri
-
Animal Model of Substance Abuse Behavior S10-329Animal Model of Substance Abuse Behavior